On Friday, British American Tobacco (BAT) announced that they were ready to test a Covid-19 vaccine made from the protein of tobacco leaves.
The tobacco company says that they have sent a pre-investigative new drug application to the American Food and Drug Administration for approval, after finding positive results in the pre-clinical phase.
According to Bloomberg, the vaccine gets its genetic structure from the virus that causes Covid-19. BAT believes that this process will make the developing of the vaccine faster than most others and that their vaccine will need a mere six weeks to be processed. The company has previously mentioned that it would be able to process 1 million to 3 million doses per week if they get the necessary backing.
BAT says that they expect to start clinical trials of the vaccine in June.